Suppr超能文献

生殖器带状疱疹可能是艾滋病毒感染的指标。

Genital Herpes Zoster as Possible Indicator of HIV Infection.

作者信息

Ljubojević Hadžavdić Suzana, Kovačević Maja, Skerlev Mihael, Zekan Šime

机构信息

Associate Professor Suzana Ljubojević Hadžavdić, MD, PhD, Department of Dermatology and Venereology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Šalata 4, 10000 Zagreb, Croatia;

出版信息

Acta Dermatovenerol Croat. 2018 Dec;26(4):337-338.

Abstract

Herpes zoster (HZ) is an acute, cutaneous viral infection caused by the reactivation of varicella-zoster virus (VZV) (1). It is a frequent medical condition with an incidence rate of 2-3 cases per 1000 person/years in the general population and 7-10 cases per 1000 person/years after the age of 50 (1,2). Risk factors and triggers for reactivation of HZV have not yet been determined precisely, but are likely to include malignancies, immune deficiencies, solid organ and bone marrow transplant recipients, autoimmune diseases, psychological conditions, emotional stress, human immunodeficiency virus (HIV) infection, and other patients receiving immunosuppressive therapies (1,3). A 24-year-old IV drug user presented with grouped clusters of vesicles and erosions on an erythematous, edematous base distributed on the left side of the penile shaft and the left infraumbilical region (Figure 1, a and b), with regional lymphadenopathy. He had prodromal symptoms of pain, dysesthesia and burning a few days prior to the appearance of the skin lesion. The patient reported unprotected sexual contacts a few months before the eruptions. The unilateral distribution was highly suggestive of herpes zoster. A Tzanck smear was performed by obtaining scrapings from the base of a fresh vesicular lesion after it had been unroofed; it showed the characteristic presence of multinucleated giant cells that suggested herpes infection. Polymerase chain reaction (PCR) analysis of vesicular fluid yielded positive results for VZV. A 7-day course of acyclovir (800 mg 5 times a day) was initiated. The patient reported marked improvement on the second day of antiviral therapy. The course was uncomplicated, and the lesions healed without postherpetic neuralgia. Serologic tests for syphilis (VDRL/RPR and TPHA) and hepatitis C and B serologic tests were negative, but HIV test (enzyme immunoassays (EIA) for HIV-1 and HIV-2 antibodies were positive, which was later confirmed with Western blot (WB) tests. Because of the positive HIV test, the patient was referred to the Clinic for Infectious Diseases for further treatment. Herpes zoster is painful vesicular skin eruption with unilateral dermatomal involvement, usually with a severe impact on the quality of life in affected patients (1). The risk for developing HZ during a lifetime in patients exposed to VZV infection is 10-30% (4). However, the risk is higher in immunocompromised patients, particularly in cancer patients and HIV-positive patients (1,5,6). HZ is seen approximately 7 times more frequent in patients with HIV infection (5). Reactivated VZV infection may occur at any stage of HIV infection and may be the first clinical evidence of HIV infection. The development of HZ in immunocompromised individuals can be explain by decline in cell-mediated immunity and CD4 count (6). HZ predominantly affects the thoracic region, followed by the head, cervical, and lumbar regions (1). Sacral dermatomes are involved in only up to 2% of cases (1). HZ involving the penis is rarely reported, with only few case reports in the literature (3,7-9). Birch et al. compared VZV and herpes simplex virus (HSV) in specimens obtained from the genital lesions of adults presenting with presumed genital herpes infection (10). They found VZV in nearly 3% of virus-positive genital specimens, which demonstrates that this virus needs to be considered in the differential diagnosis of genital herpetic lesions (10) and that it is possible that genital HZ infection is underdiagnosed. Tzanck smear is a rapid and inexpensive method, but it cannot differentiate VZV from HSV. Genital HZ could be mistaken for zosteriform HSV infection, so a PCR test should be performed to confirm the underlying diagnosis (1). Genital forms of HZ are rare and sometimes clinically difficult to diagnose, especially when the typical zosteriform distribution is lacking; PCR testing is therefore suggested. HZ is considered a possible HIV indicator; an HIV test should therefore be performed. According to our knowledge and literature search, this is the first case report of penile HZ in an HIV-positive patient.

摘要

带状疱疹(HZ)是由水痘-带状疱疹病毒(VZV)重新激活引起的一种急性皮肤病毒感染(1)。它是一种常见的病症,普通人群的发病率为每1000人/年2 - 3例,50岁以后每1000人/年7 - 10例(1,2)。VZV重新激活的危险因素和触发因素尚未完全确定,但可能包括恶性肿瘤、免疫缺陷、实体器官和骨髓移植受者、自身免疫性疾病、心理状况、情绪压力、人类免疫缺陷病毒(HIV)感染以及其他接受免疫抑制治疗的患者(1,3)。一名24岁的静脉吸毒者,阴茎干左侧和左脐下区域出现红斑、水肿基础上的成簇水疱和糜烂(图1,a和b),伴有局部淋巴结肿大。在皮肤病变出现前几天,他有疼痛、感觉异常和烧灼感等前驱症状。患者报告在皮疹出现前几个月有不安全性接触。单侧分布强烈提示带状疱疹。通过从新鲜水疱病变破溃后的底部刮取组织进行Tzanck涂片检查;显示有特征性的多核巨细胞,提示疱疹感染。水疱液的聚合酶链反应(PCR)分析VZV呈阳性。开始给予阿昔洛韦7天疗程(800毫克,每日5次)。患者报告在抗病毒治疗第二天有明显改善。病程无并发症,病变愈合且无带状疱疹后神经痛。梅毒血清学检测(VDRL/RPR和TPHA)以及丙型和乙型肝炎血清学检测均为阴性,但HIV检测(HIV - 1和HIV - 2抗体的酶免疫测定(EIA)呈阳性,随后经免疫印迹(WB)检测证实。由于HIV检测呈阳性,该患者被转诊至传染病诊所进行进一步治疗。带状疱疹是一种疼痛性水疱性皮肤疹,单侧累及皮节,通常对受影响患者的生活质量有严重影响(1)。暴露于VZV感染的患者一生中发生HZ的风险为10% - 30%(4)。然而,免疫功能低下的患者风险更高,尤其是癌症患者和HIV阳性患者(1,5,6)。HIV感染患者中HZ的发生率大约高7倍(5)。重新激活的VZV感染可能发生在HIV感染的任何阶段,并且可能是HIV感染的首个临床证据。免疫功能低下个体中HZ的发生可通过细胞介导免疫和CD4计数下降来解释(6)。HZ主要累及胸部区域,其次是头部、颈部和腰部区域(1)。骶部皮节受累的病例仅占2%(1)。累及阴茎的HZ很少见报道,文献中仅有少数病例报告(3,7 - 9)。Birch等人比较了VZV和单纯疱疹病毒(HSV)在疑似生殖器疱疹感染的成年人生殖器病变标本中的情况(10)。他们在近3%的病毒阳性生殖器标本中发现了VZV,这表明在生殖器疱疹样病变的鉴别诊断中需要考虑这种病毒(10),并且生殖器HZ感染可能未被充分诊断。Tzanck涂片是一种快速且廉价的方法,但它无法区分VZV和HSV。生殖器HZ可能被误诊为带状疱疹样HSV感染,因此应进行PCR检测以确诊(1)。生殖器形式的HZ很少见,有时在临床上难以诊断,特别是当缺乏典型的带状疱疹样分布时;因此建议进行PCR检测。HZ被认为是一种可能的HIV指标;因此应进行HIV检测。据我们所知及文献检索,这是首例HIV阳性患者阴茎HZ的病例报告。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验